ArticleJournal of oral microbiology2026
Human papilloma virus (HPV) infection associated with cyclosporine-induced gingival overgrowth in renal transplant recipients.
Article in Journal of oral microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Immunosuppressive drugs may lead some individuals to develop gingival overgrowth abnormalities, which may be associated with HPV infection. Objective: This study investigated the frequency of HPV subtypes in renal transplant recipients (RTRs) and healthy volunteers (HC) to evaluate the influence of cyclosporine-induced (RT-GH+C) and tacrolimus-induced (RT+T) immunosuppression on oral lesions. Methods: HPV-DNA were detected in gingival tissue and saliva using PCRRFLP and Results: HPV-DNA frequency in gingival tissue and saliva was 2.53- and 2.24-fold higher in RTRs compared to HC with HPV-16 being the most frequent subtype among RTRs. We observed a higher HPV frequency in RTRs using cyclosporine compared to HC group with periodontal disease (HC-PD). However, no significant difference was found in the HPV-DNA frequency between RTRs treated with tacrolimus and HC. Conclusion: The high frequency of HPV infection observed in RTR patients using cyclosporine may be associated with the immunosuppression caused by this drug. However, since this is a cross-sectional study, the exposure and outcome are observed simultaneously; and therefore, they may not be related. In any case, we believe that oral lesions in these individuals should be monitored to prevent the development of malignant lesions, such as oral cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.